Citation Formats
Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. SANCER Et Al. , "Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, pp.788-795, 2022

SANCER, O. Et Al. 2022. Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3 , 788-795.

SANCER, O., ASLAN KOŞAR, P., TEPEBAŞI, M. Y., ERGÜN, O., DEMİR, M., & KOŞAR, A., (2022). Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, 788-795.

SANCER, Okan Et Al. "Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, 788-795, 2022

SANCER, Okan Et Al. "Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, pp.788-795, 2022

SANCER, O. Et Al. (2022) . "Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.3, pp.788-795.

@article{article, author={Okan SANCER Et Al. }, title={Determination of miRNA expression profiile in patients with prostate cancer and benign prostate hyperplasia}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2022, pages={788-795} }